Continued transplant immunosuppression may prolong survival after return to peritoneal dialysis: Results of a decision analysis

American Journal of Kidney Diseases - Tập 40 - Trang 178-183 - 2002
Sarbjit V. Jassal1, Charmaine E. Lok1, Aziz Walele1, Joanne M. Bargman1
1Division of Nephrology, University Health Network, and Department of Medicine, University of Toronto, Ontario, Canada

Tài liệu tham khảo

Canadian Institute for Health Information, 1996, Volume 2 Obrador, 1999, Level of renal function at the initiation of dialysis in the U.S. end-stage renal disease population, Kidney Int, 56, 2227, 10.1038/sj.ki.4491163 Herlitz H, Harris K, Risler T, et al: The effects of an ACE inhibitor and a calcium antagonist on the progression of renal disease: The Nephros Study. Nephrol Dial Transplant 16:2158-2165, 200. Bargman, 2001, Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study, J Am Soc Nephrol, 12, 2158, 10.1681/ASN.V12102158 Shemin, 2001, Residual renal function and mortality risk in hemodialysis patients, Am J Kidney Dis, 38, 85, 10.1053/ajkd.2001.25198 Moist, 2000, Predictors of loss of residual renal function among new dialysis patients, J Am Soc Nephrol, 11, 556, 10.1681/ASN.V113556 Andrew, 1996, Impaired outcome of continuous ambulatory peritoneal dialysis in immunosuppressed patients, Nephrol Dial Transplant, 11, 1104, 10.1093/oxfordjournals.ndt.a027463 Gregoor, 1997, Infections after renal allograft failure in patients with or without low-dose maintenance immunosuppression, Transplantation, 63, 1528, 10.1097/00007890-199705270-00028 Vychytil, 2001, New strategies to prevent Staphylococcus aureus infections in peritoneal dialysis patients, J Am Soc Nephrol, 9, 669, 10.1681/ASN.V94669 Sonnenberg, 1993, Markov models in medical decision making: A practical guide, Med Decis Making, 13, 322, 10.1177/0272989X9301300409 Vincenti, 2001, Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation, Transplantation, 71, 1282, 10.1097/00007890-200105150-00017 McGeown, 2000, One thousand renal transplants at Belfast City Hospital: Post graft neoplasia 1968-1999, comparing azathioprine only with cyclosporin-based regimes in a single centre, 193 Sheil, 1999, Patterns of malignancies following renal transplantation, Transplant Proc, 31, 1263, 10.1016/S0041-1345(98)01988-5 Birkeland, 2000, Cancer risk in patients on dialysis and after renal transplantation, Lancet, 355, 1886, 10.1016/S0140-6736(00)02298-4 Thiagarajan, 1998, Malignancies in renal transplant recipients, Transplant Proc, 30, 3154, 10.1016/S0041-1345(98)00974-9 Ghods, 2000, Lymphoma—the most common neoplasia in renal transplant recipients, Transplant Proc, 32, 585, 10.1016/S0041-1345(00)00900-3 Maisonneuve, 1999, Cancer in patients on dialysis for end-stage renal disease: An international collaborative study, Lancet, 354, 93, 10.1016/S0140-6736(99)06154-1 Danpanich, 1999, Risk factors for cancer in renal transplant recipients, Transplantation, 68, 1859, 10.1097/00007890-199912270-00008